What's new

Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 18, Status: Authorised

Feb 18, 2025 - 17:14
 0
Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

J&J MedTech restarts Varipulse's US rollout after stroke reports

Next Article

A Tesla Model S For $9,000?

Related Posts

Demonstration of efficacy for veterinary medicinal products containing antimicrobial substances - Scientific guideline

Demonstration of efficacy for veterinary medicinal prod...

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Copalia, amlodipine,valsartan, Date of authorisation: 15/01/2007, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

European Medicines Agency post-authorisation procedural...

Feb 18, 2025  0